期刊文献+

羟基喜树碱、小剂量顺铂配合氟脲嘧啶持续输注治疗晚期胃癌临床观察 被引量:1

Clinical Observation on Combination Chemotherapy with HCPT Low Dose DDP and 5-FU Continuous Infusion in the Treatment of Advanced Gastric Cancer
下载PDF
导出
摘要 目的 观察羟基喜树碱、小剂量顺铂配合氟脲嘧啶持续输注治疗晚期胃癌的近期疗效和毒副反应。方法  3 6例晚期胃癌予以羟基喜树碱 (HCPT) 10mg静滴d1~ 5 ,顺铂 (DDP) 6mg/ (m2 ·d)静滴 ,每周连续 5天 ,氟脲嘧啶 ( 5_Fu) 0 2 5 / (m2 ·d)通过微量注射器深静脉持续输注 2 4h ,连续应用 2 1d为 1周期 ,休息 10d后重复 ,2周期以上评定疗效及毒副作用。结果  3 6例晚期胃癌中 ,CR 2例( 5 6% ) ,PR 16例 ( 4 4 4% ) ,CR +PR 5 0 0 %。毒副作用为恶心呕吐、白细胞减少和黏膜炎 ,多为Ⅰ~Ⅱ度 ,患者可以耐受。结论 羟基喜树碱及小剂量顺铂配合氟脲嘧啶持续输注治疗晚期胃癌近期疗效确切 ,毒副作用轻微 ,有临床应用价值。 Objective To evaluate the efficacy and toxicity of HCPT,low dose DDP and 5_FU continuous infusion for treatment of advanced gastric cancer.Methods A total of 36 patients were enrolled in the trial.HCPT 10 mg by intravenous titration d1~5,DDP 6mg/(m 2·d) by intravenous titration during the first day to the fifth day every week,5_Fu 0.25/(m 2·d) every day by continuous infusion for 3 weeks,every 31 days,Each patient was given at least 2 cycles.Results A complete response was observed in 2 cases and a partial response in 16 cases,and overall response rate of 50.0%.Toxic effects included nausea,leukopenia and vomiting,Main side effects were grade Ⅰ~Ⅱ.Conclusion This study confirmed that combination chemotherapy with HCPT,low dose DDP and 5_Fu continuous infusion is a safe and effective regimen for patients with advanced gastric cancer and is worthy of further clinical trial.
出处 《河南肿瘤学杂志》 2003年第6期404-405,共2页 Henan Journal of Oncology
关键词 羟基喜树碱 顺铂 氟脲嘧啶 晚期胃癌 临床观察 毒副作用 HCPT DDP 5-Fu chemotherapy advanced gastric cancer
  • 相关文献

参考文献2

二级参考文献6

  • 1[1]Roth BJ, Johnson DH, Einhorn LH, et al. Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase Ⅲ trial of Southeastern Cancer Study Group [J]. J Clin Oncol, 1992, 10(2): 282-291.
  • 2[2]Fukuoka M, Furuse K,Saijo N,et al. Randomized trial of cyclophosphamide, doxorubicin, and vincristine versus cisplatin and etoposide versus alternation of these regimens in small-cell lung cancer [J]. J Natl Cancer Inst,1991,83(12): 855-861.
  • 3[3]Shepherd FA, Evans WK, MacCormick R, et al. Cyclophosphamide, doxorubicin, and vincristine in etoposide and cisplatin-resistant small cell lung cancer [J]. Cancer Treat Rep, 1987, 71(10): 941-944.
  • 4[4]Ardizzoni A, Hansen H, Dombernowsky P, et al. Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: A phase II study in patients with refractory and sensitive disease [J]. J Clin Oncol, 1997, 15(5): 2090-2096.
  • 5[5]Von-Pawel J, Schiller JH, Shepherd FA, et al. Topotecan versus cyclophosphamide, doxorubicin,and vincristine for treatment of recurrent small cell lung cancer [J]. J Clin Oncol, 1999, 17(2): 658-667.
  • 6[6]Perez-Soler R, Glisson BS, Lee JS, et al. Treatment of patients with small-cell lung cancer refractory to etoposide and cisplatin with the topoisomerase I poison topotecan [J]. J Clin Oncol, 1996, 14(10): 2785-2790.

共引文献51

同被引文献8

  • 1乔学英 周道安.中晚期食管癌放射治疗配合卡铂的远期疗效[J].中华放射肿瘤学杂志,1997,6(2):118-119.
  • 2Hermanek P,Sobin LH. TNM classification of malignant tumors (UICC) [M]. Berlin: Springer Verlag,1987.40-41.
  • 3Mucke R,Ziegler PG,Libera T,et al. The multimodality therapy of advanced inoperable esophageal carcinoma. A retrospective analysis [J]. Strahlenther Onkol,2000,176(8) : 350- 355.
  • 4Kaneta T,Takai Y,Nemoto K,et al. Effects of combination chemoradiotherapy with daily low-dose CDDP for esophageal cancer-results of a randomized trial[J]. Gan To Kagaku Ryoho, 1997, 24 (14) : 2099 -2104.
  • 5Al-Sarraf M, Martz K,Herskovic A,et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer. An intergroup study [J]. J Clin Oncol,1997,15(2):866.
  • 6Herskovic A, Martz K, A1-Sarraf M,et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus[J]. N Engl J Med,1992,326(24):1593-1598.
  • 7金懋林.胃癌化学治疗的发展与运用[J].中国肿瘤临床,2000,27(10):792-798. 被引量:150
  • 8安继业,王立东.食管癌单独化疗和联合放疗、化疗的应用进展[J].实用肿瘤杂志,2003,18(6):493-495. 被引量:14

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部